共 50 条
Photodynamic therapy for early-stage cervical cancer treatment
被引:17
|作者:
Afanasiev, Maxim S.
[1
]
Dushkin, Alexander D.
[2
]
Grishacheva, Tatyana G.
[3
]
Afanasiev, Stanislav S.
[4
]
Academician, Alexander V. Karaulov
[1
]
机构:
[1] Sechenov Univ, IM Sechenov First Moscow State Med Univ, 8-2 Trubetskaya Str, Moscow 119991, Russia
[2] Loginov Moscow Clin Sci Ctr Loginov MCSC MHD, Moscow Hlth Dept, 86 Enthusiasts Highway, Moscow 111123, Russia
[3] First Pavlov State Med Univ St Petersburg, Lva Tolstogo Str 6-8, St Petersburg 197022, Russia
[4] GN Gabrichevsky Moscow Res Inst Epidemiol & Micro, 10 Admiral Makarov Str, Moscow 125212, Russia
关键词:
Photodynamic therapy;
Cervical cancer;
Human papillomavirus;
Immune response;
APOPTOSIS;
D O I:
10.1016/j.pdpdt.2021.102620
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background: The aim of this article is a retrospective analysis of PDT effectiveness in the treatment in early-stage cervical cancer and also analysis of HPV elimination via PDT Material and methods: A total of 28 patients were analyzed retrospectively, all with PDT treatment for early-stage cervical cancer. Patients underwent one PDT session or a multi-course PDT approach. This depended on individual reaction and response to therapy after the first session. A multi-course approach was performed over two months. Treatments were performed from 2015 to 2020. Relapse-free probability was assessed for these patients by Kaplan Meier estimator at 60 months and HPV elimiantion was also examined.. Results: HPV elimination was in 82% of cases in three-month period after PDT (R-2 = 0.71). Among the analyzed cases, full HPV elimination was detected in more than 90% of cases. Relapse-free probability from cervical cancer is 0,8 (CI95%: 0,53-1) at 60 months. Patients had mild (35.7%) and severe (28.6%) leucocyte reactions after PDT in three months. Conclusion: The article demonstrates treatment results for CC and detected a five-year period relapse-free probability after PDT. Patients completing a multi-treatment PDT protocol for invasive cervical cancer can achieve both high response rate and relapse-free survival.
引用
收藏
页数:9
相关论文